advertisement
Chen H 49
Showing records 1 to 25 | Display all abstracts from Chen H118848 Antioxidant potential of chlorogenic acid in Age-Related eye diseases
Tang Y
Pharmacology research & perspectives 2024; 12: e1162
117384 Malignant glaucoma treated by low-dose laser cycloplasty: a 1-year multicenter prospective non-comparative study
Lin HS
International Journal of Ophthalmology 2024; 17: 1248-1254
117744 Ferroptosis in Glaucoma: A Promising Avenue for Therapy
Zhu J
Advanced biology 2024; 8: e2300530
117266 The causal effect of oxidative stress on the risk of glaucoma
Shi R
Heliyon 2024; 10: e24852
117336 Mechanism and treatment of secondary glaucoma after corneal transplantation: a review
Lin Y
Frontiers in ophthalmology 2024; 4: 1361704
116764 Effect of the gut microbiome in glaucoma risk from the causal perspective
Wu Y
BMJ open ophthalmology 2024; 9:
117883 Rho Kinase (ROCK) Inhibitors for the Treatment of Glaucoma
Wu J
Current Drug Targets 2024; 25: 94-107
117266 The causal effect of oxidative stress on the risk of glaucoma
Wu Y
Heliyon 2024; 10: e24852
117384 Malignant glaucoma treated by low-dose laser cycloplasty: a 1-year multicenter prospective non-comparative study
Xu XP
International Journal of Ophthalmology 2024; 17: 1248-1254
118848 Antioxidant potential of chlorogenic acid in Age-Related eye diseases
Fang C
Pharmacology research & perspectives 2024; 12: e1162
117744 Ferroptosis in Glaucoma: A Promising Avenue for Therapy
Chen H
Advanced biology 2024; 8: e2300530
117336 Mechanism and treatment of secondary glaucoma after corneal transplantation: a review
Gou Q
Frontiers in ophthalmology 2024; 4: 1361704
116764 Effect of the gut microbiome in glaucoma risk from the causal perspective
Shi R
BMJ open ophthalmology 2024; 9:
117883 Rho Kinase (ROCK) Inhibitors for the Treatment of Glaucoma
Wei J
Current Drug Targets 2024; 25: 94-107
118848 Antioxidant potential of chlorogenic acid in Age-Related eye diseases
Shi J
Pharmacology research & perspectives 2024; 12: e1162
117384 Malignant glaucoma treated by low-dose laser cycloplasty: a 1-year multicenter prospective non-comparative study
Zheng XL
International Journal of Ophthalmology 2024; 17: 1248-1254
116764 Effect of the gut microbiome in glaucoma risk from the causal perspective
Chen H
BMJ open ophthalmology 2024; 9:
117744 Ferroptosis in Glaucoma: A Promising Avenue for Therapy
Wu J
Advanced biology 2024; 8: e2300530
117384 Malignant glaucoma treated by low-dose laser cycloplasty: a 1-year multicenter prospective non-comparative study
Zheng XL
International Journal of Ophthalmology 2024; 17: 1248-1254
117883 Rho Kinase (ROCK) Inhibitors for the Treatment of Glaucoma
Chen H
Current Drug Targets 2024; 25: 94-107
117336 Mechanism and treatment of secondary glaucoma after corneal transplantation: a review
Yu P
Frontiers in ophthalmology 2024; 4: 1361704
117266 The causal effect of oxidative stress on the risk of glaucoma
Chen H
Heliyon 2024; 10: e24852
117384 Malignant glaucoma treated by low-dose laser cycloplasty: a 1-year multicenter prospective non-comparative study
Zheng XL
International Journal of Ophthalmology 2024; 17: 1248-1254
117336 Mechanism and treatment of secondary glaucoma after corneal transplantation: a review
Wu Z
Frontiers in ophthalmology 2024; 4: 1361704
116764 Effect of the gut microbiome in glaucoma risk from the causal perspective
Zhang Z
BMJ open ophthalmology 2024; 9:
